SlidesetHIVViral Hepatitis and Liver DiseaseTransitioning from International to Domestic Funding: Experiences in the Asia Pacific- Ravipa Vannakit, RN, MScView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseTransitioning to Sustainable Mechanisms for Priority Public Health Programmes in The Western Pacific- Naoko Ishikawa, MD, MSc, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseNovel Treatment Strategies for LMICs- Pedro Cahn, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseTurning Challenges into Opportunities: Preventing and Treating HIV Infection among Adolescents- Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVSView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseIntroduction to HIV Persistence on ART- Denise Hsu, BSc, MBBS, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseOverview of Clinical Trials for HIV Cure- James McMahon, MBBS, FRACP, MPH, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseDiagnosing and Treating Acute HIV Infection – Implications for HIV Cure- Eugène Kroon, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseKey Population Community Engagement- Matthew Avery, MPHView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseKey Pop-led HIV Service Delivery – Focus on Transgenders- Rena Janamnuaysook, MBAView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseControversies in Management of Latent Tuberculosis Infection in People Living With HIV Infection in the Asia Pacific Region - Chi Chiu Leung , MBBS, MRCP, FCCP, FHKCP, FHKAM, FFPH, FHKCCMView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseDebate: Same-day ART should be implemented in HIV treatment programs in the Asia-Pacific: Pro- Iskandar Azwa, MBChB, MRCP, DIP GUM, DIP HIVView Slideset
SlidesetHIVViral Hepatitis and Liver DiseasePrevention of Cryptococcosis and Other Aids-Related Fungal Infections: Strategies for the Asia Pacific Region- David Boulware, MD, MPH, CTropMedView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseDebate: Same-day ART should be implemented in HIV treatment programs in the Asia-Pacific: Con- Edsel Salvana, MD, DTM&H, FPCP, FIDSAView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseMinimum STI package in HIV care and prevention for LMIC - Reshmie Ramautarsing, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseHepatitis B Therapy Pipeline: How Far Are We From Cure- Peter Revill, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEpidemic of Acute HCV: What Have We Learned?- Chien-Ching Hung, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseProvider’s Perspective of PrEP Demedicalization- Heather-Marie Schmidt, BMedSc (Hon), MPH, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCommunity Perspective of Demedicalization of PrEP- Danvic RosadiñoView Slideset
